Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting. - Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ (Genes, 2020)